Literature DB >> 1719740

Immunochemistry of ethylnitrosourea-induced rat neurinomas, the RN6 neurinoma cell line and their transplantation tumors.

K T Vogeley1, T Bilzer, G Reifenberger, W Wechsler.   

Abstract

The expression of glial fibrillary acidic protein (GFAP), vimentin, S-100 protein (S-100), HNK-1, myelin basic protein (MBP) and fibronectin was investigated immunohistochemically in 51 ethylnitrosourea (ENU)-induced neurinomas of the rat. Additionally, 90 transplantation tumors derived from ENU-induced neurinomas and the RN6 rat neurinoma cell clone were studied. Vimentin immunoreactivity was shown in 50/51 primary neurinomas and 60/90 transplantation tumors. In contrast, GFAP was expressed in only 23/51 primary tumors and in 5/90 transplantation tumors. In the RN6 neurinoma clone, vimentin and GFAP could be demonstrated both in vivo and in vitro. GFAP expression varied depending on the tumor localization, i.e., tumors of distal portions of peripheral nerves were more frequently GFAP positive than tumors of the spinal roots or of cranial nerves. The same tendency was observed for S-100. In the series of transplantation tumors S-100 and GFAP immunoreactivity decreased with increasing numbers of transplantation passages. Only individual cells in 5 primary tumors were HNK-1 positive and no MBP-immunoreactive cells were observed. Our results demonstrate that the expression of differentiation antigens in ENU-induced experimental neurinomas parallels the results reported for human neurinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719740     DOI: 10.1007/bf00310927

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  40 in total

1.  S-100 protein in methyl- and ethylnitrosourea induced tumors of the rat nervous system.

Authors:  W Wechsler; S E Pfeiffer; J A Swenberg; A Koestner
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

2.  Biological characteristics of peripheral nerve tumors induced with ethylnitrosourea.

Authors:  H Cravioto; J F Weiss; E de C Weiss; H H Goebel; J Ransohoff
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

3.  An experimental model for selective production of neoplasms of the peripheral nervous system.

Authors:  R H Denlinger; A Koestner; J A Swenberg
Journal:  Acta Neuropathol       Date:  1973-02-19       Impact factor: 17.088

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.

Authors:  G Reifenberger; T Bilzer; R J Seitz; W Wechsler
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Experimental model of tumors associated with neurofibromatosis.

Authors:  A Cardesa; T Ribalta; B Von Schilling; A Palacín; U Mohr
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

Review 7.  Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors.

Authors:  M Miettinen; V P Lehto; I Virtanen
Journal:  Ultrastruct Pathol       Date:  1984       Impact factor: 1.094

8.  Myelin basic protein and P2 protein are not immunohistochemical markers for Schwann cell neoplasms. A comparative study using antisera to S-100, P2, and myelin basic proteins.

Authors:  H B Clark; J J Minesky; D Agrawal; H C Agrawal
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

9.  Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases.

Authors:  Y Daimaru; H Hashimoto; M Enjoji
Journal:  Am J Surg Pathol       Date:  1985-06       Impact factor: 6.394

10.  Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.

Authors:  E Kawahara; Y Oda; A Ooi; S Katsuda; I Nakanishi; S Umeda
Journal:  Am J Surg Pathol       Date:  1988-02       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.